Literature DB >> 12111768

Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high Hb F.

A D Adekile1, F Yacoub, R Gupta, T Sinan, M Z Haider, Y Habeeb, M Al-Bloushi, A Moosa.   

Abstract

Overt stroke is rare among sickle cell disease (SCD) patients in Kuwait. However, there are no previous studies of silent cerebral infarcts, which have been described in up to 20% of American children with Hb SS. We have carried out a prospective brain MRI study among otherwise normal SCD patients, who were consecutive patients seen in a 1-year period to document the prevalence of silent cerebral infarcts in children with sickle cell disease in Kuwait. Any patient with a previous seizure or other neurological abnormality was excluded. MRI was done with a 1.5 Tesla unit with super-conducting magnet. T1- and T2-weighted sagittal and axial sections and proton density axial images were obtained in 5-mm thick sections. The study group consisted of 30 (23 SS and 7 Sbeta(0)Thal) patients-19 males and 11 females-whose ages ranged from 6 to 17 (mean of 9.8 +/- 3.5) years. Hb F ranged from 11% to 35% with a mean of 22.8% +/- 5.7%. Only one patient, a 10-and-a-half-year-old boy with Hb SS, showed hyperintense signals in the parietal white matter, consistent with small infarcts, thus giving a prevalence of 3.3%. Silent brain infarcts are uncommon in our patients, and the protective factors remain to be fully elucidated. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111768     DOI: 10.1002/ajh.10143

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  13 in total

1.  Sickle cell anemia and academic achievement in Africa.

Authors:  Ayokunle T Abegunde
Journal:  J Natl Med Assoc       Date:  2005-10       Impact factor: 1.798

2.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2016-10

Review 3.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

4.  Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease.

Authors:  Rodney T Perry; Debra A Gearhart; Howard W Wiener; Lindy E Harrell; James C Barton; Abdullah Kutlar; Ferdane Kutlar; Ozan Ozcan; Rodney C P Go; William D Hill
Journal:  Neurobiol Aging       Date:  2006-12-08       Impact factor: 4.673

5.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

6.  Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.

Authors:  Anwar Al-Awadhi; Adekunle Adekile; Rajaa Marouf
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

7.  Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.

Authors:  Abdulrahman Alsultan; Mohammed K Alabdulaali; Paula J Griffin; Ahmed M Alsuliman; Hazem A Ghabbour; Paola Sebastiani; Waleed H Albuali; Amein K Al-Ali; David H K Chui; Martin H Steinberg
Journal:  Br J Haematol       Date:  2013-11-13       Impact factor: 6.998

8.  Correlating transcranial arterial Doppler velocities with haematologic parameters and haemolytic indices of Nigerian children with sickle cell anaemia.

Authors:  Anas Ismail; Aminu Abba Yusuf; Aisha Kuliya-Gwarzo; Sagir Gumel Ahmed; Abdulkadir Musa Tabari; Shehi Ali Abubakar
Journal:  Ultrasound       Date:  2019-03-09

Review 9.  Epidemiology of sickle cell disease in Saudi Arabia.

Authors:  Wasil Jastaniah
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

Review 10.  The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.

Authors:  Adekunle Adekile
Journal:  Med Princ Pract       Date:  2020-09-04       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.